Virtu Financial’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

Virtu Financial’s Portfolio LABP Stock Details LABP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,537	Closed	-$313K	–	2104
2024 Q1	$313K	Buy	+14,537	New	+$96.4K	0.02%	601

Virtu Financial's LABP Position: Q2 2024 in Review

Virtu Financial sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2024, closing a stake of 14,537 shares — an estimated $313K sold.

Virtu Financial first reported a position in LABP in Q1 2024 and held it in 1 quarter. The position peaked at $313K in Q1 2024. 0 funds tracked by Wall St. Rank hold LABP as of Q2 2024.

Virtu Financial reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Virtu Financial sold 14,537 Landos Biopharma, Inc. Common Stock shares in Q2 2024, an estimated $313K.
Virtu Financial first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Virtu Financial's Landos Biopharma, Inc. Common Stock position peaked at $313K in Q1 2024.
0 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.